2200 PENNSYLVANIA AVE NW, WASHINGTON, DC
Market cap: $361.7M (2/11/2026)
Price: $6.12
Earnings Release
Announces Receipt of FDA Decision Letter on HETLIOZ® Supplemental New Drug Application for Jet Lag Disorder
Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness
Provides Regulatory Update on Tradipitant for Motion Sickness
Reports Third Quarter 2025 Financial Results
Reports Second Quarter 2025 Financial Results
Shareholder votes
FY 2024
Q3
Q2
Q1
FY 2023
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Amended Registration of Securities
Registration of Securities
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Confidential Treatment Order